Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Centene Corporation (CNC : NYSE)
 
 • Company Description   
Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Through a diversified product portfolio and expanding geographic reach, Centene continues to deliver results by growing premium and service revenues profitably. The company operates in two segments: Managed Care and Specialty Services. Managed Care - This segment provides health plan coverage to individuals through Government subsidized programs, including Medicaid. Specialty Services - This segment consists of its specialty companies offering diversified healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups and other commercial organizations.

Number of Employees: 60,500

 
 • Price / Volume Information   
Yesterday's Closing Price: $41.15 Daily Weekly Monthly
20 Day Moving Average: 5,188,235 shares
Shares Outstanding: 491.52 (millions)
Market Capitalization: $20,225.97 (millions)
Beta: 0.48
52 Week High: $66.81
52 Week Low: $25.08
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 5.92% 6.10%
12 Week 8.78% 7.02%
Year To Date 0.00% 0.00%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
7700 FORSYTH BOULEVARD
-
ST LOUIS,MO 63105
USA
ph: 314-725-4477
fax: 314-558-2428
investors@centene.com http://www.centene.com
 
 • General Corporate Information   
Officers
Sarah M. London - Chief Executive Officer
Andrew L. Asher - Executive Vice President; Chief Financial Officer
Katie N. Casso - Senior Vice President; Finance; Corporate Controll
Jessica L. Blume - Director
Kenneth A. Burdick - Director

Peer Information
Centene Corporation (JUNP.)
Centene Corporation (GNOW)
Centene Corporation (CI)
Centene Corporation (OHP)
Centene Corporation (SFGH)
Centene Corporation (HUM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-HMO
Sector: Medical
CUSIP: 15135B101
SIC: 6324
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/25
Next Expected EPS Date: 02/03/26
Share - Related Items
Shares Outstanding: 491.52
Most Recent Split Date: 2.00 (2.00:1)
Beta: 0.48
Market Capitalization: $20,225.97 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $1.92 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $2.94 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 8.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 15.00% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 02/03/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 14.01
Trailing 12 Months: 10.19
PEG Ratio: 0.93
Price Ratios
Price/Book: 0.96
Price/Cash Flow: 4.16
Price / Sales: 0.11
EPS Growth
vs. Year Ago Period: -69.14%
vs. Previous Quarter: 412.50%
Sales Growth
vs. Year Ago Period: 18.24%
vs. Previous Quarter: 1.94%
ROE
12/31/25 - -
09/30/25 - 7.82
06/30/25 - 9.57
ROA
12/31/25 - -
09/30/25 - 2.38
06/30/25 - 3.10
Current Ratio
12/31/25 - -
09/30/25 - 1.08
06/30/25 - 1.10
Quick Ratio
12/31/25 - -
09/30/25 - 1.08
06/30/25 - 1.10
Operating Margin
12/31/25 - -
09/30/25 - 1.08
06/30/25 - 1.47
Net Margin
12/31/25 - -
09/30/25 - -2.85
06/30/25 - 1.15
Pre-Tax Margin
12/31/25 - -
09/30/25 - -2.60
06/30/25 - 1.55
Book Value
12/31/25 - -
09/30/25 - 42.79
06/30/25 - 55.98
Inventory Turnover
12/31/25 - -
09/30/25 - -
06/30/25 - -
Debt-to-Equity
12/31/25 - -
09/30/25 - 0.83
06/30/25 - 0.64
Debt-to-Capital
12/31/25 - -
09/30/25 - 45.51
06/30/25 - 38.98
 

Powered by Zacks Investment Research ©